Related Experiment Video
Updated: Apr 15, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.3K
Upgrading prostate cancer following proton beam therapy
Jennifer K Logan1, Soroush Rais-Bahrami1, Maria J Merino2
1Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Urology Annals
|April 4, 2015
Summary
Radiation therapy (RT) dosage correlates with prostate cancer changes, but effects vary. Understanding these post-RT histologic changes is crucial for evaluating residual tumor in prostate cancer patients.
Area of Science:
- Oncology
- Pathology
Background:
- Histologic changes in prostate tissue following radiation therapy (RT) are not fully understood.
- A dose-response relationship between escalating RT dosage and post-RT histologic alterations appears to exist.
- Radiation-induced changes can be heterogeneous within tumors and among patients.
Observation:
- A case study of a 45-year-old man with poorly differentiated prostate adenocarcinoma is presented.
- The patient received proton beam RT for Gleason 4 + 3 = 7 disease.
- An elevated serum prostate-specific antigen level was noted prior to RT.
Findings:
- The study highlights the importance of understanding biopsy evaluation in the post-RT setting.
- It underscores the variability of radiation-induced histologic changes.
- The correlation between radiation dose and observed changes is noted.
Implications:
- Accurate assessment of residual prostate cancer post-RT requires careful consideration of histologic changes.
- Further research is needed to elucidate the mechanisms and variability of RT-induced prostate tissue alterations.
- This understanding can aid in refining treatment strategies and improving patient outcomes in prostate cancer management.
